模拟辅助剂选择对尼托拉胺形成的影响,以缓解风险
Alberto Berardi1, Maarten Jaspers1, Bastiaan H J Dickhoff1
1DFE Pharma, Klever Str. 187, 47574 Goch, Germany.
仔细选择药物辅助剂可以显著减少药物产品中的尼托拉胺杂质. 改变辅助剂供应商或类型可以将尼特罗斯胺的形成降低高达89%.
科学领域:
- 制药化学 制药化学 制药化学
- 制造业 制造业 制造业 制造业 制造业
- 不纯度控制 不纯度控制
背景情况:
- 尼胺杂质在药物制品中构成重大风险,由与含氨酸物质反应的亚酸盐形成.
- 辅助剂的酸盐含量和反应速率是尼托胺形成的关键因素,但辅助剂选择的影响还没有得到充分研究.
研究的目的:
- 系统地调查辅助剂选择如何影响药物产品中的尼特罗斯胺形成.
- 通过战略性辅助剂选择来量化尼托拉胺水平的潜在降低.
主要方法:
- 开发了理论案例研究,改变了微晶纤维素 (MCC),乳糖供应商或超级分解剂类型.
- 基于文献中的配方,亚酸盐含量,分子量和转化率计算了罗斯胺的形成.
主要成果:
- 单一辅助剂供应商的更换使得尼托拉胺的形成减少了高达59%.
- 修改三种关键辅助剂降低了89%的尼托拉胺的形成.
- 高风险配方可以通过辅助剂选择来降低风险,以达到监管限制.
结论:
- 战略性辅助剂选择是减轻药品中尼胺杂质风险的强大工具.
- 为药物配方中初步风险评估和辅助剂影响评估提供了一个开放访问工具.
更多相关视频
13:54A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
Published on: August 18, 2023
08:25Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
相关概念视频
2° Amines to N-Nitrosamines: Reaction with NaNO2
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
